• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗前中性粒细胞与淋巴细胞比值是头颈部鳞状细胞癌的独立预后因素:Meta 分析和试验序贯分析。

Pre-treatment neutrophil-to-lymphocyte ratio is an independent prognostic factor in head and neck squamous cell carcinoma: Meta-analysis and trial sequential analysis.

机构信息

Multidisciplinary Department of Medical-Surgical and Odontostomatological Specialties, University of Campania "Luigi Vanvitelli", Naples, Italy.

Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.

出版信息

J Oral Pathol Med. 2022 Jan;51(1):39-51. doi: 10.1111/jop.13264. Epub 2021 Dec 9.

DOI:10.1111/jop.13264
PMID:34797592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9299721/
Abstract

Inflammation seems to play a critical role in the development and progression of different cancers. Neutrophil-to-lymphocyte ratio (NLR) is an easily measurable marker of systemic inflammation. The purpose of this systematic review and meta-analysis was to evaluate the prognostic role of the pre-treatment NLR, in terms of overall survival (OS) and disease-free survival (DFS), in patients with primary head and neck squamous cell carcinoma (HNSCC) treated by surgery alone or followed by chemo/radiotherapy. This systematic review was performed according to the guidelines reported in the Cochrane Handbook and the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement. Meta-analysis of OS and DFS was performed using the inverse of variance test. Fixed-effect models were used on the basis of the presence of heterogeneity. Risk of bias assessment and trial sequential analysis (TSA) were also performed; the quality of the evidence was evaluated via the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach. The analysis revealed that a higher value of pre-treatment NLR correlates with a statistically significant decrease of OS (HR, 1.56; 95% CI: [1.35, 1.80]; p < 0.00001) and a lower DFS (HR, 1.64; 95% CI: [1.30, 2.07]; p < 0.0001) in HNSCC patients.

摘要

炎症似乎在不同癌症的发展和进展中起着关键作用。中性粒细胞与淋巴细胞比值(NLR)是一种易于测量的全身炎症标志物。本系统评价和荟萃分析的目的是评估术前 NLR 在接受单纯手术或放化疗治疗的原发性头颈部鳞状细胞癌(HNSCC)患者的总生存率(OS)和无病生存率(DFS)方面的预后作用。本系统评价按照 Cochrane 手册和系统评价和荟萃分析的 Preferred Reporting Items(PRISMA)声明中报告的指南进行。使用方差倒数检验进行 OS 和 DFS 的荟萃分析。基于异质性的存在,使用固定效应模型。还进行了偏倚风险评估和试验序贯分析(TSA);通过 Grading of Recommendations, Assessment, Development and Evaluation(GRADE)方法评估证据质量。分析表明,术前 NLR 值较高与 OS(HR,1.56;95%CI:[1.35, 1.80];p<0.00001)和 DFS(HR,1.64;95%CI:[1.30, 2.07];p<0.0001)显著降低相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce5f/9299721/150d0079738b/JOP-51-39-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce5f/9299721/2a4c87d75623/JOP-51-39-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce5f/9299721/a684b1aab895/JOP-51-39-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce5f/9299721/0384b1167c2f/JOP-51-39-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce5f/9299721/150d0079738b/JOP-51-39-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce5f/9299721/2a4c87d75623/JOP-51-39-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce5f/9299721/a684b1aab895/JOP-51-39-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce5f/9299721/0384b1167c2f/JOP-51-39-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce5f/9299721/150d0079738b/JOP-51-39-g001.jpg

相似文献

1
Pre-treatment neutrophil-to-lymphocyte ratio is an independent prognostic factor in head and neck squamous cell carcinoma: Meta-analysis and trial sequential analysis.治疗前中性粒细胞与淋巴细胞比值是头颈部鳞状细胞癌的独立预后因素:Meta 分析和试验序贯分析。
J Oral Pathol Med. 2022 Jan;51(1):39-51. doi: 10.1111/jop.13264. Epub 2021 Dec 9.
2
The Prognostic Role of miR-31 in Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis with Trial Sequential Analysis.miR-31 在头颈部鳞状细胞癌中的预后作用:系统评价和试验序贯分析的荟萃分析。
Int J Environ Res Public Health. 2022 Apr 27;19(9):5334. doi: 10.3390/ijerph19095334.
3
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.根治性子宫切除术联合放化疗与单纯根治性子宫切除术治疗局部晚期宫颈癌的疗效比较
Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD010260. doi: 10.1002/14651858.CD010260.pub3.
6
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
7
The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.肿瘤相关巨噬细胞在头颈部鳞状细胞癌中的预后作用:系统评价和荟萃分析。
Oral Oncol. 2022 Dec;135:106227. doi: 10.1016/j.oraloncology.2022.106227. Epub 2022 Nov 3.
8
Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.治疗胶质母细胞瘤进展或复发的选择:网络荟萃分析。
Cochrane Database Syst Rev. 2021 May 4;5(1):CD013579. doi: 10.1002/14651858.CD013579.pub2.
9
The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: Results from a systematic review and meta-analysis.XRCC1 Arg194Trp 多态性与头颈部鳞状细胞癌发生风险相关:系统评价和荟萃分析结果。
Cancer Rep (Hoboken). 2023 Mar;6(3):e1776. doi: 10.1002/cnr2.1776. Epub 2022 Dec 27.
10
Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.超根治性(广泛)手术与标准手术治疗晚期上皮性卵巢癌的初步细胞减灭术。
Cochrane Database Syst Rev. 2022 Aug 30;8(8):CD007697. doi: 10.1002/14651858.CD007697.pub3.

引用本文的文献

1
Prognostic factors in advanced incurable HNSCC patients on palliative-intent immunotherapy-based regimen.基于姑息性免疫治疗方案的晚期不可治愈头颈部鳞状细胞癌患者的预后因素。
Future Sci OA. 2025 Dec;11(1):2552067. doi: 10.1080/20565623.2025.2552067. Epub 2025 Aug 28.
2
Prognostic value of pretreatment peripheral blood biomarkers in patients with head and neck squamous cell carcinoma treated with chemo/bioradiotherapy.化疗/生物放疗治疗的头颈部鳞状细胞癌患者治疗前外周血生物标志物的预后价值
Clin Transl Oncol. 2025 May 5. doi: 10.1007/s12094-025-03897-y.
3
Retrospective Analysis of Blood Inflammatory Biomarkers in Patients with Oral Lichen Planus: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio.

本文引用的文献

1
Head and neck squamous cell carcinoma.头颈部鳞状细胞癌
Nat Rev Dis Primers. 2020 Nov 26;6(1):92. doi: 10.1038/s41572-020-00224-3.
2
Predictors of early progression after curative resection followed by platinum-based adjuvant chemoradiotherapy in oral cavity squamous cell carcinoma.口腔鳞状细胞癌根治性切除术后接受铂类辅助放化疗后早期进展的预测因素。
Postgrad Med. 2021 Apr;133(3):377-384. doi: 10.1080/00325481.2020.1809869. Epub 2020 Sep 11.
3
Prognostic value of systemic inflammatory markers for oral cancer patients based on the 8th edition of AJCC staging system.
口腔扁平苔藓患者血液炎症生物标志物的回顾性分析:中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值
J Clin Med. 2024 Dec 9;13(23):7490. doi: 10.3390/jcm13237490.
4
Hematological biomarkers of systemic inflammation in predicting long-term treatment response of temporomandibular disorders.颞下颌关节紊乱系统炎症的血液生物标志物预测其长期治疗反应。
BMC Oral Health. 2024 Sep 16;24(1):1097. doi: 10.1186/s12903-024-04862-x.
5
From Tumor Macroenvironment to Tumor Microenvironment: The Prognostic Role of the Immune System in Oral and Lung Squamous Cell Carcinoma.从肿瘤宏观环境到肿瘤微环境:免疫系统在口腔和肺鳞状细胞癌中的预后作用
Cancers (Basel). 2024 Aug 3;16(15):2759. doi: 10.3390/cancers16152759.
6
A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer.抗程序性死亡配体1(PD-L1)免疫检查点抑制剂联合化疗治疗初治广泛期小细胞肺癌的临床分析
Vaccines (Basel). 2024 Apr 29;12(5):474. doi: 10.3390/vaccines12050474.
7
MicroRNA expression as a prognostic biomarker of tongue squamous cell carcinoma (TSCC): a systematic review and meta-analysis.miRNA 表达作为舌鳞状细胞癌 (TSCC) 的预后生物标志物:系统评价和荟萃分析。
BMC Oral Health. 2024 Mar 31;24(1):406. doi: 10.1186/s12903-024-04182-0.
8
The Neutrophil-to-Lymphocyte Ratio as a Biomarker in Cutaneous Oncology: A Systematic Review of Evidence beyond Malignant Melanoma.中性粒细胞与淋巴细胞比值作为皮肤肿瘤生物标志物的研究:恶性黑色素瘤以外证据的系统评价
Cancers (Basel). 2024 Mar 4;16(5):1044. doi: 10.3390/cancers16051044.
9
[Establishment and verification of a prognostic nomogram for survival of tongue squamous cell carcinoma patients who underwent cervical dissection].[接受颈清扫术的舌鳞状细胞癌患者生存预后列线图的建立与验证]
Beijing Da Xue Xue Bao Yi Xue Ban. 2024 Feb 18;56(1):120-130. doi: 10.19723/j.issn.1671-167X.2024.01.019.
10
Dietary Polyphenols against Oxidative Stress in Head and Neck Cancer: What's New, What's Next.膳食多酚对头颈部癌氧化应激的作用:新进展与未来方向
J Cancer. 2024 Jan 1;15(2):293-308. doi: 10.7150/jca.90545. eCollection 2024.
基于第 8 版 AJCC 分期系统的全身性炎症标志物对口腔癌患者预后的价值。
Sci Rep. 2020 Jul 21;10(1):12111. doi: 10.1038/s41598-020-68991-3.
4
Neutrophil-lymphocyte ratio associated with poor prognosis in oral cancer: a retrospective study.中性粒细胞与淋巴细胞比值与口腔癌预后不良相关:一项回顾性研究。
BMC Cancer. 2020 Jun 17;20(1):568. doi: 10.1186/s12885-020-07063-1.
5
Nomogram Based on Systemic Immune-Inflammation Index to Predict Survival of Tongue Cancer Patients Who Underwent Cervical Dissection.基于全身免疫炎症指数的列线图预测接受颈清扫术的舌癌患者的生存情况
Front Oncol. 2020 Mar 11;10:341. doi: 10.3389/fonc.2020.00341. eCollection 2020.
6
Prognostic value of systemic inflammatory marker in patients with head and neck squamous cell carcinoma undergoing surgical resection.系统炎症标志物对接受手术切除的头颈部鳞状细胞癌患者的预后价值。
Future Oncol. 2020 Apr;16(10):559-571. doi: 10.2217/fon-2020-0010. Epub 2020 Mar 13.
7
Neutrophil-To-Lymphocyte and Platelet-To-Lymphocyte Ratios as Prognostic Markers of Survival in Patients with Head and Neck Tumours-Results of a Retrospective Multicentric Study.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值作为头颈部肿瘤患者生存预后的标志物:一项回顾性多中心研究的结果。
Int J Environ Res Public Health. 2020 Mar 7;17(5):1742. doi: 10.3390/ijerph17051742.
8
Prognosis Value of Platelet Counts, Albumin and Neutrophil-Lymphocyte Ratio of Locoregional Recurrence in Patients with Operable Head and Neck Squamous Cell Carcinoma.血小板计数、白蛋白及中性粒细胞与淋巴细胞比值对可手术头颈部鳞状细胞癌患者局部区域复发的预后价值
Cancer Manag Res. 2020 Jan 31;12:731-741. doi: 10.2147/CMAR.S234618. eCollection 2020.
9
Assessment of Pretreatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Prognosis of Oral Squamous Cell Carcinoma.口腔鳞状细胞癌预后中治疗前中性粒细胞/淋巴细胞比值和血小板/淋巴细胞比值的评估
J Oral Maxillofac Surg. 2020 Jun;78(6):949-960. doi: 10.1016/j.joms.2020.01.001. Epub 2020 Jan 9.
10
Preoperative platelet-lymphocyte ratio predicts recurrence of laryngeal squamous cell carcinoma.术前血小板-淋巴细胞比值可预测喉鳞状细胞癌的复发。
Future Oncol. 2020 Feb;16(6):209-217. doi: 10.2217/fon-2019-0527. Epub 2020 Jan 27.